about
[(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptorsConstitutive neuropeptide Y Y(4) receptor expression in human colonic adenocarcinoma cell linesNeuropeptide Y: A hypothalamic brake restraining the onset of puberty in primatesThe role of NPY in metabolic homeostasis: implications for obesity therapy.BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonistNovel dimeric DOTA-coupled peptidic Y1-receptor antagonists for targeting of neuropeptide Y receptor-expressing cancers.Neuropeptide Y receptors: ligand binding and trafficking suggest novel approaches in drug development.Intermolecular Peptide Cross-Linking by Using Diaminodicarboxylic Acids.Molecular imaging probes derived from natural peptides.Functional reconstitution of human neuropeptide Y (NPY) Y(2) and Y(4) receptors in Sf9 insect cells.Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells.Novel analogues of neuropeptide Y with a preference for the Y1-receptor.New insights into vascular reactivity: from altered structure to neural control.Synthesis and characterization of a selective peptide antagonist of neuropeptide Y vascular postsynaptic receptors.Discrimination between neuropeptide Y and peptide YY in the rat tail artery by the neuropeptide Y1-selective antagonist, BIBP 3226.Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.Neuropeptide Y (NPY) Y1 receptor mRNA is upregulated in association with transient hyperphagia and body weight gain: evidence for a hypothalamic site for concurrent development of leptin resistance.Neuropeptide Y receptor antagonists in obesity.Synthetic routes to the Neuropeptide Y Y1 receptor antagonist 1229U91 and related analogues for SAR studies and cell-based imaging.In Vitro Mouse and Human Serum Stability of a Heterobivalent Dual-Target Probe That Has Strong Affinity to Gastrin-Releasing Peptide and Neuropeptide Y1 Receptors on Tumor Cells.Modified, cyclic dodecapeptide analog of neuropeptide Y is the smallest full agonist at the human Y2receptor
P2860
Q28343949-AC5F8034-2591-4CBC-B2B9-921A9DCBE745Q28345909-ABFE5AB3-0769-4A59-AE68-AD95A26887F6Q28776576-FD287D59-2CBA-4A64-BE30-7549CF5FA6EBQ34074911-18E091A8-6E0A-492B-AAB0-59D9C203725BQ35042022-08CD5BB4-17EE-4683-BE62-272F11A67796Q35650466-23307DDD-A59D-4FEE-BA95-EA7B05923309Q37847125-F9AE8817-79C3-4F88-9E66-D8A9E2FAD887Q38691393-46367645-F8A8-4B58-A8EC-782FD4815CE0Q38748846-0C03787A-567F-4ACB-BE52-828B803D381FQ39509078-2405DEFD-F369-4EDC-841C-E4F61E28401DQ40678238-FEF500AB-66EB-40F8-B2D0-0BD6C86054BDQ40805267-B7A16489-0C6D-4B99-9AEB-6165C8817B2BQ41464537-769658F5-9AA8-4757-97CE-10204BB42398Q41784280-BF53C397-8C8C-46EA-9FF3-C11D59DDA5F7Q42581670-25A17A52-FE66-4E25-9C58-3E212BFEADEFQ43263299-758BA04F-E0E5-4532-83A6-CDA8043E096EQ47293432-13AE5697-614B-4832-9E2E-05CD37A82F31Q48827578-6EACD31D-BB1F-43D4-A7F2-0B6DB9E33A9BQ50457650-5720D68E-4E31-4291-912D-B8E9270C38C9Q50899749-A54B9854-2D91-403B-BCD2-741F7C95D61AQ56426242-3FC5336C-1937-496F-A4E0-DE168320A700
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
High-affinity neuropeptide Y receptor antagonists.
@ast
High-affinity neuropeptide Y receptor antagonists.
@en
type
label
High-affinity neuropeptide Y receptor antagonists.
@ast
High-affinity neuropeptide Y receptor antagonists.
@en
prefLabel
High-affinity neuropeptide Y receptor antagonists.
@ast
High-affinity neuropeptide Y receptor antagonists.
@en
P2093
P2860
P356
P1476
High-affinity neuropeptide Y receptor antagonists.
@en
P2093
Daniels AJ
Harrington W
Landavazo A
Matthews JE
Slepetis RJ
Spaltenstein A
Tadepalli A
P2860
P304
P356
10.1073/PNAS.92.20.9067
P407
P577
1995-09-01T00:00:00Z